The chemical composition of some marketed AMPs. For gramicidin D and teicoplanin, only one of the most ample parts in the clinically used mixtures are shown. The Peptide Report is devoted to the timely disclosure of the look and results of interventional clinical studies, ensuring transparency and accessibility. • The Peptide Report research c